Hemorrhagic complications after treatment with defibrotide in a case of severe veno-occlusive disease

Medicina Clinica

Volumn 118, Issue 13, 2002, Pages 518-519

  Palomera, Luis ^a   Sola, Carlos ^a   Domingo, José M ^b   Arruga, Ana ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b Anatomía Patológica del Hospital Reina Sofía de Tudela   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; DEFIBROTIDE; POLYDEOXYRIBONUCLEOTIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUSULFAN; CYCLOPHOSPHAMIDE; D DIMER; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE;

BLEEDING; CASE REPORT; CHEMICALLY INDUCED DISORDER; HOSPITALIZATION; HUMAN; LETTER; LIVER VEIN OBSTRUCTION; MALE; MIDDLE AGED; ADULT; BLOOD CLOTTING; BONE MARROW TRANSPLANTATION; BRAIN HEMATOMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; GRAFT REJECTION; LIVER BIOPSY; LIVER VENOOCCLUSIVE DISEASE; MYELODYSPLASTIC SYNDROME; SEPTIC SHOCK; SOMNOLENCE; THROMBOCYTE COUNT;

HEMORRHAGE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POLYDEOXYRIBONUCLEOTIDES; SEVERITY OF ILLNESS INDEX;

EID: 0037070881     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72437-8     Document Type: Letter

References (10)

1. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
2. The syndrome of hepatic veno-occlusive disease after marrow transplantation
3. Incidence and outcome of hepatic veno-occlusive disease after blood or bone marrow transplantation. A prospective cohort study of the European Group for Blood and Marrow transplantation
4. Venoocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation
5. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1
6. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients
7. Defibrotide: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders
8. Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms
9. Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate-use study
10. Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population